Detecting colistin resistance in hospital infections
Part of Infections clinical trials.
This study is looking at bacteria from hospital patients that are hard to treat because they resist many antibiotics, including a last-resort medicine called colistin. By testing these bacteria, researchers hope to find better ways to stop the spread of drug-resistant infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a hospitalized patient at Assiut University Hospitals.
- The infection must be caused by a type of bacteria called 'gram-negative' (your doctor can confirm).
- The bacteria must be resistant to multiple antibiotics (multidrug-resistant).
- The bacteria must also be resistant to carbapenem, a strong type of antibiotic.
- Only one sample per patient is used for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
This study tests which of two antibiotic combinations works better at clearing infections caused by multi-drug-resistant bacteria in adults, including those with weakened immune systems. It aims to find a more effective treatment option.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
This study tests different ways of giving the antibiotic colistin to patients in the ICU with infections that are hard to treat. The goal is to find the best dosing schedule to help you fight the infection more effectively.
This study looks at how Klebsiella pneumoniae bacteria that are resistant to many antibiotics form a protective layer (biofilm) and pump out drugs (efflux pump activity). By understanding these mechanisms, doctors may find better ways to treat these tough infections.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
Hear when a new Patients With Multi Drug Resistant Gram-negative Bacteria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.